MOLECULIN BIOTECH INC's ticker is MBRX and the CUSIP is 60855D101. A total of 24 filers reported holding MOLECULIN BIOTECH INC in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $32,000 | -17.9% | 34,944 | -0.4% | 0.00% | – |
| Q3 2019 | $39,000 | 0.0% | 35,088 | +11.7% | 0.00% | – |
| Q2 2019 | $39,000 | +290.0% | 31,411 | +151.7% | 0.00% | – |
| Q1 2019 | $10,000 | -23.1% | 12,478 | 0.0% | 0.00% | – |
| Q4 2018 | $13,000 | -35.0% | 12,478 | +0.3% | 0.00% | – |
| Q3 2018 | $20,000 | -9.1% | 12,442 | -0.3% | 0.00% | – |
| Q2 2018 | $22,000 | 0.0% | 12,478 | +3.7% | 0.00% | – |
| Q1 2018 | $22,000 | -4.3% | 12,033 | -3.5% | 0.00% | – |
| Q4 2017 | $23,000 | -28.1% | 12,472 | -5.3% | 0.00% | – |
| Q3 2017 | $32,000 | +52.4% | 13,172 | +16.9% | 0.00% | – |
| Q2 2017 | $21,000 | -19.2% | 11,263 | -47.8% | 0.00% | – |
| Q1 2017 | $26,000 | +550.0% | 21,592 | +1442.3% | 0.00% | – |
| Q4 2016 | $4,000 | 0.0% | 1,400 | +100.0% | 0.00% | – |
| Q3 2016 | $4,000 | -50.0% | 700 | -41.7% | 0.00% | – |
| Q2 2016 | $8,000 | – | 1,200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Whitegate Investment Counselors, Inc. | 101,781 | $81,000 | 0.01% |
| Levy Wealth Management Group, LLC | 14,036 | $11,000 | 0.01% |
| WOODMONT INVESTMENT COUNSEL LLC | 12,000 | $10,000 | 0.00% |
| Renaissance Technologies | 948,503 | $756,000 | 0.00% |
| Qube Research & Technologies Ltd | 132,238 | $105,000 | 0.00% |
| Core Wealth Advisors, Inc. | 1,711 | $1,000 | 0.00% |
| UBS Group AG | 36,726 | $29,000 | 0.00% |
| IFP Advisors, Inc | 0 | $0 | 0.00% |
| Squarepoint Ops LLC | 12,342 | $10,000 | 0.00% |
| TRUE Private Wealth Advisors | 2,500 | $1,000 | 0.00% |